| 1 | KYMR | Kymera Therapeutics, Inc. | 4.03% |
| 2 | ALKS | Alkermes plc | 3.73% |
| 3 | MIRM | Mirum Pharmaceuticals, Inc. | 3.39% |
| 4 | CELC | Celcuity Inc. | 3.24% |
| 5 | GPCR | Structure Therapeutics Inc. | 2.99% |
| 6 | FOLD | Amicus Therapeutics, Inc. | 2.96% |
| 7 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.86% |
| 8 | CGON | CG Oncology, Inc. | 2.67% |
| 9 | ACAD | ACADIA Pharmaceuticals Inc. | 2.67% |
| 10 | NAMS | NewAmsterdam Pharma Company N.V. | 2.45% |
| 11 | APGE | Apogee Therapeutics, Inc. | 2.29% |
| 12 | XENE | Xenon Pharmaceuticals Inc. | 2.10% |
| 13 | VKTX | Viking Therapeutics, Inc. | 2.00% |
| 14 | IRON | Disc Medicine, Inc. | 1.99% |
| 15 | DNLI | Denali Therapeutics Inc. | 1.98% |
| 16 | EWTX | Edgewise Therapeutics, Inc. | 1.94% |
| 17 | APLS | Apellis Pharmaceuticals, Inc. | 1.92% |
| 18 | IDYA | IDEAYA Biosciences, Inc. | 1.87% |
| 19 | TVTX | Travere Therapeutics, Inc. | 1.77% |
| 20 | TARS | Tarsus Pharmaceuticals, Inc. | 1.77% |
| 21 | VERA | Vera Therapeutics, Inc. | 1.76% |
| 22 | SYRE | Spyre Therapeutics, Inc. | 1.72% |
| 23 | MLYS | Mineralys Therapeutics, Inc. | 1.50% |
| 24 | GLPG | Galapagos NV | 1.47% |
| 25 | MAZE | Maze Therapeutics, Inc. | 1.42% |
| View SBIO holdings |
